Korean J Otorhinolaryngol-Head Neck Surg.  2010 May;53(5):275-283. 10.3342/kjorl-hns.2010.53.5.275.

The Analysis of Prognostic Factor and Treatment Outcome of Malignancies of the External Auditory Canal

Affiliations
  • 1Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul, Korea. junlee@snu.ac.kr
  • 2Sensory Organ Reserah Institute, Seoul National University Medical Research Center, Seoul, Korea.
  • 3Department of Otolaryngology, Seoul National University Bundang Hospital, Seoul, Korea.

Abstract

BACKGROUND AND OBJECTIVES
The purpose of this study was to analyze the survival rate treatment modalities and certain prognostic factors in patients with external auditory canal (EAC) cancer using the University of Pittsburgh TNM Staging System.
SUBJECTS AND METHOD
Medical records and radiological findings of 33 patients treated for EAC cancer between January 1995 and January 2009 were reviewed retrospectively. The median follow-up period was 65 months (range, 12-182 months).
RESULTS
The most common histological type was squamous cell carcinoma (19 patients; 57.6%), followed by adenoid cystic carcinoma (9 patients; 27.3%), basal cell carcinoma (1 patient), adenocarcinoma (1 patient), rhabdomyosarcoma (1 patient), undifferentiated carcinoma (1 patient) and malignant small round cell tumor (1 patient). Seven of 33 patients died of EAC cancer and the overall survival rate was 70.6%. There was a significant difference in the survival rate with respect to TNM stages (p=.031). The 10 yr-survival rate of patients with stage I disease was 100.0%, whereas those of stages II, III and IV were 50.0, 80.0 and 58.3%, respectively. Five of 7 patients with recurrence had a history of initial positive resection margin.
CONCLUSION
Early detection and proper surgical treatment with sufficient resection margin are essential for disease-specific survival and prevention of recurrence in patients with EAC cancer.

Keyword

External auditory canal; Cancer; Prognosis

MeSH Terms

Adenocarcinoma
Aminocaproic Acids
Carcinoma
Carcinoma, Adenoid Cystic
Carcinoma, Basal Cell
Carcinoma, Squamous Cell
Ear Canal
Follow-Up Studies
Humans
Medical Records
Neoplasm Staging
Prognosis
Recurrence
Retrospective Studies
Rhabdomyosarcoma
Survival Rate
Treatment Outcome
Aminocaproic Acids
Full Text Links
  • KJORL-HN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr